Jane Street Group, LLC Roivant Sciences Ltd. Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 14,596 shares of ROIV stock, worth $167,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,596
Previous 2,507,783
99.42%
Holding current value
$167,708
Previous $26.5 Million
99.37%
% of portfolio
0.0%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$758 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$756 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$622 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$479 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$406 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.09B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...